摘要
目的:探讨经皮穿刺引流和尿激酶局部注射治疗创伤性肾包膜下血肿的价值.方法:闭合性肾损伤并发肾包膜下巨大血肿患者8例,出血停止1～3周后,在B超定位下行经皮血肿穿刺引流术,引流出陈旧性出血后,每隔3～4天向血肿内注入50～20万U尿激酶并保留24 h,然后充分引流.结果:穿刺引流后3～4天引流出陈旧性积血(81±32)ml.间断注射尿激酶溶解血凝块,20～35天后,血肿体积约为治疗前的1/15～1/50.经12～34个月随访,无继发性出血、感染、高血压等并发症.结论:对闭合性肾损伤肾包膜下巨大血肿患者行经皮血肿穿刺引流术,同时局部应用尿激酶溶解血凝块,可有效溶解引流肾包膜下陈旧性出血和血凝块,具有推广价值.
Objective:To investigate the value of percutaneous drainage of the hematoma and local application of urokinase to treat traumatic subcapsular renal hematoma.Methods:Percutaneous drainage of the hematoma was undertaken to treat 8 patients with traumatic subcapsular renal hematoma, then 500,000 to 200,000 IU urokinase was injected in subcapsular renal hematoma and reserved 24 hours every other 3 or 4 days.Results:(81±32) ml old blood was poured in the first 3 days. The volume of subcapsular renal hematoma decreasd gradually after urokinase was injected. Followed up for 12~34 months the complications of active bleeding,infection and hypertension were not found.Conclusions:Percutaneous drainage of the hematoma and local application of urokinase are better method to treat traumatic subcapsular renal hematoma.
出处
《临床泌尿外科杂志》
2005年第3期145-146,共2页
Journal of Clinical Urology
关键词
肾创伤
肾包膜下血肿
引流
尿激酶
Trauma
Subcapsular renal hematoma
Drainage
Urokinase
